Integrative pathway enrichment analysis of multivariate omics data
暂无分享,去创建一个
Nuno A. Fonseca | Gary D Bader | Benjamin J. Raphael | Natalie S. Fox | Calvin Wing Yiu Chan | Joshua M. Stuart | Keith A. Boroevich | Lincoln D. Stein | Dale W. Garsed | Patrick D. McGillivray | Miles W. Mee | M. Gerstein | C. Sander | Manolis Kellis | T. Pons | G. Getz | S. Brunak | A. Hobolth | M. Rubin | D. Wheeler | R. Beroukhim | S. C. Sahinalp | J. Korbel | T. Tsunoda | Ekta Khurana | J. S. Pedersen | P. Campbell | P. Boutros | J. Komorowski | C. Wadelius | Rory Johnson | A. Gonzalez-Perez | C. Rubio-Perez | D. Tamborero | I. Gut | J. Reimand | Guanming Wu | L. Zou | Jaegil Kim | G. Saksena | Jordi Deu-Pons | L. Mularoni | R. Sabarinathan | I. Martincorena | H. Hornshøj | M. Nielsen | Malene Juul | Tobias Madsen | K. Marchal | S. Schumacher | A. Harmanci | A. Kahraman | C. von Mering | A. Kahles | Youngwook Kim | Keunchil Park | G. Tiao | L. Lochovsky | J. Choi | Sushant Kumar | Jing Zhang | J. Hess | J. Izarzugaza | J. Weischenfeldt | J. L. Fink | D. Chakravarty | M. Vazquez | C. Herrmann | N. Haradhvala | Esther Rheinbay | Y. Maruvka | H. Nakagawa | M. Shackleton | M. Helmy | Ken Chen | Keren Isaev | S. Lou | S. Waszak | L. Verbeke | J. Warrell | F. Muiños | I. Reyes-Salazar | O. Pich | F. Abascal | K. Lehmann | Shantao Li | Jiayin Wang | S. Amin | E. M. Liu | K. Diamanti | L. Salichos | Joana Carlevaro-Fita | Yan Zhang | H. Umer | Donghoon Lee | H. Zhu | C. Gambacorti-Passerini | L. Feuerbach | D. Haan | L. Sieverling | P. Dhingra | O. Shapira | Johanna Bertl | Qianyun Guo | T. A. Johnson | J. Barenboim | J. Frigola | Ermin Hodzic | Chen Hong | R. Juul | J. K. Kim | Xiaotong Li | Ziao Lin | Alexander Martínez-Fundichely | William Meyerson | M. Paczkowska | Sergio Pulido-Tamayo | M. Reyna | Ciyue Shen | Raunak Shrestha | Liis Uusküla-Reimand | Lina Wadi | Xuanping Zhang | A. Valencia | Nikos Sidiropoulos | Nardnisa Sintupisut | Zhongming Zhao | Jun Yu | D. Abd-Rabbo | Kiejung Park | Natalie C. Fox | S. Shuai | Federico Samirkumar B. Gary D. Rameen Johanna Keith A. Søre Abascal Amin Bader Beroukhim Bertl Boroe | Andrés Lanzós | Helen Zhu | Mike S. Lawrence | Nasa Sinnott-Armstrong | M. P. Hamilton | Ferran Muiños | M. Vázquez | William U. Meyerson | D. W. Garsed | Natalie C. Fox
[1] Nuno A. Fonseca,et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.
[2] Nuno A. Fonseca,et al. Author Correction: Integrative pathway enrichment analysis of multivariate omics data , 2020, Nature Communications.
[3] Jun Yu,et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes , 2020, Nature.
[4] A. Kahraman,et al. Pathogenic impact of isoform switches in 1209 cancer samples covering 27 cancer types using an isoform-specific interaction network , 2019, bioRxiv.
[5] Natalie S. Fox,et al. Landscape of transcriptomic interactions between breast cancer and its microenvironment , 2019, Nature Communications.
[6] Natalie S. Fox,et al. The Proteogenomic Landscape of Curable Prostate Cancer. , 2019, Cancer cell.
[7] Gary D Bader,et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap , 2019, Nature Protocols.
[8] Barcelona Institute of Science and Technology , 2018, The Grants Register 2019.
[9] Benjamin J. Raphael,et al. Hierarchical HotNet: identifying hierarchies of altered subnetworks , 2018, Bioinform..
[10] Kathleen Marchal,et al. Pathway and network analysis of more than 2,500 whole cancer genomes , 2018, bioRxiv.
[11] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[12] Benoît Ballester,et al. ReMap 2018: an updated atlas of regulatory regions from an integrative analysis of DNA-binding ChIP-seq experiments , 2017, Nucleic Acids Res..
[13] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[14] Lucas Lochovsky,et al. Discovery and characterization of coding and non-coding driver mutations in more than 2,500 whole cancer genomes , 2017, bioRxiv.
[15] Gary D Bader,et al. Pathway enrichment analysis of -omics data , 2017, bioRxiv.
[16] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[17] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[18] Mihaela Zavolan,et al. Patterns of ribosomal protein expression specify normal and malignant human cells , 2016, Genome Biology.
[19] Kathleen Marchal,et al. SSA-ME Detection of cancer driver genes using mutual exclusivity by small subnetwork analysis , 2016, Scientific Reports.
[20] Lincoln D. Stein,et al. Impact of outdated gene annotations on pathway enrichment analysis , 2016, Nature Methods.
[21] Hedi Peterson,et al. g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..
[22] M. Burkard,et al. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer , 2016, BMC Cancer.
[23] Henning Hermjakob,et al. The Reactome pathway Knowledgebase , 2015, Nucleic acids research.
[24] Radhakrishnan Sabarinathan,et al. Nucleotide excision repair is impaired by binding of transcription factors to DNA , 2015, Nature.
[25] Bin Zhao,et al. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer , 2015, Cell.
[26] G. G. Galli,et al. YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers. , 2015, Molecular cell.
[27] Kathleen Marchal,et al. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration , 2015, PloS one.
[28] Jan O. Korbel,et al. Data analysis: Create a cloud commons , 2015, Nature.
[29] Gary D Bader,et al. Pathway and network analysis of cancer genomes , 2015, Nature Methods.
[30] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[31] Molin Wang,et al. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] K. Guan,et al. The Hippo signaling pathway in stem cell biology and cancer , 2014, EMBO reports.
[33] Xaralabos Varelas,et al. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease , 2014, Development.
[34] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[35] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[36] R. Carpenter,et al. Regulation of Apoptosis by HER2 in Breast Cancer. , 2013, Journal of carcinogenesis & mutagenesis.
[37] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .
[38] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[39] Quaid Morris,et al. Computational purification of individual tumor gene expression profiles leads to significant improvements in prognostic prediction , 2013, Genome Medicine.
[40] Lynda Chin,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.
[41] Anushya Muruganujan,et al. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees , 2012, Nucleic Acids Res..
[42] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[43] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[44] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[45] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[46] Sven Laur,et al. Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..
[47] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..
[48] Daniel Birnbaum,et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer , 2011, Breast Cancer Research and Treatment.
[49] Gary D Bader,et al. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.
[50] Gary D. Bader,et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..
[51] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[52] Bruce J. Aronow,et al. ToppCluster: a multiple gene list feature analyzer for comparative enrichment clustering and network-based dissection of biological systems , 2010, Nucleic Acids Res..
[53] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[54] Julien Textoris,et al. Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells , 2009, PloS one.
[55] A. Nobel,et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[57] Hedi Peterson,et al. g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments , 2007, Nucleic Acids Res..
[58] X. Chen,et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.
[59] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[61] Hsien-yu Wang,et al. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. , 2003, Cancer letters.
[62] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[63] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[64] Morton B. Brown. 400: A Method for Combining Non-Independent, One-Sided Tests of Significance , 1975 .